VIVUS Inc (NASDAQ:VVUS)

0.914
Delayed Data
As of May 25
 -0.0206 / -2.20%
Today’s Change
0.33
Today|||52-Week Range
1.38
+81.85%
Year-to-Date
VIVUS (VVUS) in Focus: Stock Moves 5.6% Higher
May 25 / Zacks.com - Paid Partner Content
Vivus Inc (VVUS) CEO John P. Amos Bought $248,400 of Shares
May 21 / GuruFocus News - Paid Partner Content
Vivus Inc (VVUS) CEO John P. Amos Bought $207,900 of Shares
May 22 / GuruFocus News - Paid Partner Content
 

Today’s Trading

Previous close0.93
Today’s open0.96
Day’s range0.88 - 0.99
Volume2,801,211
Average volume (3 months)1,094,031
Market cap$57.1M
Data as of 4:00pm ET, 05/25/2018

Growth & Valuation

Earnings growth (last year)-231.82%
Earnings growth (this year)-48.28%
Earnings growth (next 5 years)+0.84%
Revenue growth (last year)-47.39%
P/E ratioNM
Price/Sales0.81
Price/Book--

Competitors

 Today’s
change
Today’s
% change
GEMPGemphire Therapeutic...+0.27+4.44%
ALIMAlimera Sciences Inc+0.01+1.27%
MEIPMEI Pharma Inc-0.03-0.95%
ZFGNZafgen Inc-0.38-5.78%
Data as of 4:00pm ET, 05/25/2018

Financials

Next reporting dateAugust 2, 2018
EPS forecast (this quarter)-$0.11
Annual revenue (last year)$65.4M
Annual profit (last year)-$30.5M
Net profit margin-46.67%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
Chief Executive Officer &
Director
John P. Amos
President &
Independent Director
Thomas Braxton King
Corporate headquarters
Campbell, California

Forecasts